Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

  • Adela Castelló,

    Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain

  • Miguel Martín,

    Affiliations Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain, Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain

  • Amparo Ruiz,

    Affiliation Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain

  • Ana M. Casas,

    Affiliation Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain

  • Jose M Baena-Cañada,

    Affiliation Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain

  • Virginia Lope,

    Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain

  • Silvia Antolín,

    Affiliation Medical Oncology Unit, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain

  • Pedro Sánchez,

    Affiliation Medical Oncology Unit, Complejo Hospitalario de Jaén, Jaén, Spain

  • Manuel Ramos,

    Affiliation Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain

  • Antonio Antón,

    Affiliation Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, Spain

  • Montserrat Muñoz,

    Affiliation Medical Oncology Unit, Hospital Clinic I Provincial, Barcelona, Spain

  • Begoña Bermejo,

    Affiliation Medical Oncology Unit, Hospital Clínico, Valencia, Spain

  • Ana De Juan-Ferré,

    Affiliation Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain

  • Carlos Jara,

    Affiliation Medical Oncology Unit, Fundación Hospitalaria de Alcorcón, Alcorcón, Spain

  • José I Chacón,

    Affiliation Medical Oncology Unit, Hospital Virgen de la Salud, Toledo, Spain

  • María A. Jimeno,

    Affiliation Start-up Unit, Spanish Breast Cancer Research Group (GEICAM) Headquarters, San Sebastián De Los Reyes, Madrid, Spain

  • Petra Rosado,

    Affiliation Medical Oncology Unit, Instituto De Investigación Sanitaria Gregorio Marañón/ Universidad Complutense, Madrid, Spain

  • Elena Díaz,

    Affiliation Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain

  • Vicente Guillem,

    Affiliation Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain

  • Ana Lluch,

    Affiliation Medical Oncology Unit, Hospital Clínico, Valencia, Spain

  • Eva Carrasco,

    Affiliation Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain

  • Beatriz Pérez-Gómez,

    Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain

  • Jesús Vioque,

    Affiliations Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Epidemiology Department, Universidad Miguel Hernandez, Sant Joan d'Alacant, Spain

  • Marina Pollán ,

    mpollan@isciii.es

    Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, IIS Puerta de Hierro (IDIPHIM), Majadahonda, Madrid, Spain

  •  [ ... ],
  • EpiGEICAM researchers

    Membership of the EpiGEICAM study is provided in the Acknowledgments.

  • [ view all ]
  • [ view less ]

Abstract

Background

According to the “World Cancer Research Fund” and the “American Institute of Cancer Research” (WCRF/AICR) one in four cancer cases could be prevented through a healthy diet, weight control and physical activity.

Objective

To explore the association between the WCRF/AICR recommendations and risk of breast cancer.

Methods

During the period 2006 to 2011 we recruited 973 incident cases of breast cancer and 973 controls from 17 Spanish Regions. We constructed a score based on 9 of the WCRF/AICR recommendations for cancer prevention:: 1)Maintain adequate body weight; 2)Be physically active; 3)Limit the intake of high density foods; 4)Eat mostly plant foods; 5)Limit the intake of animal foods; 6)Limit alcohol intake; 7)Limit salt and salt preserved food intake; 8)Meet nutritional needs through diet; S1)Breastfeed infants exclusively up to 6 months. We explored its association with BC by menopausal status and by intrinsic tumor subtypes (ER+/PR+ & HER2-; HER2+; ER&PR-&HER2-) using conditional and multinomial logistic models respectively.

Results

Our results point to a linear association between the degree of noncompliance and breast cancer risk. Taking women who met 6 or more recommendations as reference, those meeting less than 3 showed a three-fold excess risk (OR=2.98(CI95%:1.59-5.59)), especially for postmenopausal women (OR=3.60(CI95%:1.24;10.47)) and ER+/PR+&HER2- (OR=3.60(CI95%:1.84;7.05)) and HER2+ (OR=4.23(CI95%:1.66;10.78)) tumors. Noncompliance of recommendations regarding the consumption of foods and drinks that promote weight gain in premenopausal women (OR=2.24(CI95%:1.18;4.28); p for interaction=0.014) and triple negative tumors (OR=2.93(CI95%:1.12-7.63)); the intake of plant foods in postmenopausal women (OR=2.35(CI95%:1.24;4.44)) and triple negative tumors (OR=3.48(CI95%:1.46-8.31)); and the alcohol consumption in ER+/PR+&HER2- tumors (OR=1.52 (CI95%:1.06-2.19)) showed the strongest associations.

Conclusion

Breast cancer prevention might be possible by following the “World Cancer Research Fund” and the “American Institute of Cancer Research” recommendations, even in settings like Spain, where a high percentage of women already comply with many of them.

Introduction

Breast cancer (BC) is the most common cancer among women worldwide and, in spite of the continuous improvements in BC prognosis, this tumor constitutes the leading cause of cancer death among women in medium and high income countries [14]. Figures in Europe indicate that the absolute number of new diagnosis and deaths due to this disease continues to increase. Comparing the most recent estimates from 2008 and 2012, breast cancer incidence has risen from 421.000 [5] cases to 458.337 [6] in Europe with the subsequent personal and economic consequences. Recently published data reveals that, in 2009, the European health-care system expended €6.73billion in the diagnosis and treatment of BC, leading the ranking in terms of expenditure (13% of all cancer-related health-care costs) [7]. According to the scientific evidence, only a 5–10% of all cancer cases are due to genetic defects and the remaining 90–95% are attributable to environmental and lifestyle factors. Concretely, tobacco, diet, infection and obesity, contribute approximately 25–30%, 30–35%, 15–20% and 10–20% respectively, providing major opportunities for prevention [8]. A recent study about research gaps for BC prevention highlights, among the main critical needs, the implementation of sustainable changes in lifestyle based on diet, exercise and weight [9]. In this context, the “World Cancer Research Fund” (WCRF) and the “American Institute of Cancer Research” (AICR) issued in 2007, 8 general and 2 special recommendations on diet, physical activity and weight management for cancer prevention based on the available evidence[10,11]: 1)Maintain adequate body weight; 2)Be physically active; 3)Limit the intake of high density foods; 4)Eat mostly plant foods; 5)Limit the intake of animal foods; 6)Limit alcohol intake; 7)Limit salt and salt preserved food intake; 8)Meet nutritional needs through diet; S1)Breastfeed infants exclusively up to 6 months.

To our knowledge, only four studies have explored the specific association between these recommendations and BC risk [1215] and none of them has classified the cases by tumor subtype considering hormonal receptors and the Human Epidermal Growth Factor Receptor 2 (HER2) status.

The objective of this study was to explore the association between WCRF/AICR recommendations and BC by menopausal status and pathological tumor subtype in Spain, a country traditionally characterized by healthy lifestyle habits.

Methods

EpiGEICAM case-control study

As we previously described [16], EpiGEICAM is a Spanish case-control study that recruited, between 2006 and 2011, 1017 incident cases of BC diagnosed in the Oncology departments of 23 hospitals members of the Spanish Breast Cancer Research Group (GEICAM: http://www.geicam.org) located in 9 of the 17 Spanish Regions. The participant oncologists invited the cases to participate in the moment of diagnosis. The inclusion criteria for cases were: age between 18 and 70 years old, agreement to participate and ability to understand and answer the questionnaire. Women previously diagnosed with breast cancer and women who were unable to answer the questionnaire due to health, language or educational issues were excluded. Each case was matched with a healthy control of similar age (± 5 years), selected from cases’ in-law relatives, friends, neighbors, or work colleagues residing in the same town.

Cases were sub classified by the following intrinsic subtypes based on local pathology reports: [17] 1) HER2- tumors (Estrogen Receptor (ER)+ or Progesterone Receptor (PR)+ with HER2-), 2) HER2+ tumors (HER2+ irrespective of ER or PR results); and 3) Triple negative tumors (ER-&PR-&HER2-). ER, PR and HER2 positivity were defined according to ASCO/CAP guidelines [18,19].

The EpiGEICAM study was approved by the Ethics Committees of all 23 participating hospitals (S4 Table). All participants signed an informed consent and patient information was anonymized and de-identified prior to analysis.

Measurements

Cases and controls completed a structured and self-administered questionnaire collecting information on demographic and anthropometric characteristics, personal, family, obstetric and gynecologic history, physical activity and diet. Postmenopausal status was defined as absence of menstruation in the last 12 months. Dietary intake in the last five years was estimated using a 117-item semi-quantitative food frequency questionnaire (FFQ) [20] adapted to and validated in different Spanish adult populations [21,22]. Upon agreement to participate, cases where invited to meet with the trained recruiters (nurses and other sanitary staff) that explained the study, proportionate the questionnaire and gave basic instructions to fill it in. In order to minimize the effect of recall bias, women were asked to respond within the following days and deliver the completed questionnaire in person within three months. They were also asked to bring their selected control in the next visit to follow the same process. The questionnaire was jointly reviewed by the participant and the interviewer in each center, who clarified those questions that the participant was not able to answer by herself.

The WCRF/AICR score was constructed following the 8 general and 2 special recommendations from WCRF/AICR report on food, nutrition and physical activity and the Continuous Update Project (CUP) for cancer prevention based on the available evidence [10,11]. Briefly, the score was based in 9 of the 10 recommendations: 1) Maintain adequate body weight; 2) Be physically active; 3) Limit the intake of high density foods; 4) Eat mostly plant foods; 5) Limit the intake of animal foods; 6) Limit alcohol intake; 7) Limit salt and salt preserved food intake; 8) Meet nutritional needs through diet; S1) Breastfeed infants exclusively up to 6 months. The special recommendation S2) for cancer survivors was not applicable to this population. A maximum score of 1 was assigned when the recommendation was fully met, an intermediate value of 0.5 when the recommendation was not far from being met and 0 points otherwise (Table 1). For the recommendations based in various subrecommendations, the final mark was calculated as the average of the subscores. The total mark was calculated as the sum of the scores in all 9 recommendations. Therefore, the WRCF/AICR score ranges from 0 to 9 and represents the minimum number of recommendations meet for each woman. The index was grouped in 5 categories [0–3[, [3–4[, [4–5[, [5,6 [and [6, 9]. The cut offs were defined as in Romaguera et al. [13] with the only exception of a wider last category. Categories “0–3” and “>3 to <4” were collapsed when the number of cases was smaller than 5.

thumbnail
Table 1. Operationalization of the WCRF/AICR in a score (0–9) using EpiGEICAM data.

https://doi.org/10.1371/journal.pone.0126096.t001

Statistical analysis

Smoking habit (<1%), age at first delivery (5%) and education (<1%) contained missing values. In order to obtain unbiased estimates of the effect of the recommendations using the information provided by all case-control pairs, missing values were imputed using multiple imputation with chained equations [23]. As explained in Royston et al [24] the chained equations method imputes missing values in different steps: Initially, all missing values are filled at random. The first variable with at least one missing value, smoking say, is then regressed on the other variables including those with missing values imputed at random in the initial step (BMI, physical activity, age at first delivery, education and age at menarche) and another set of potential explanatory variables that do not contain missing (menopausal status, age, number of children, hip and waist circumferences, bra size, calories, alcohol consumption and case/control status). The estimation is restricted to individuals with observed values for smoking and the missing values are replaced by simulated draws for the posterior predictive distribution of smoking. The next variable with missing values, say age at menarche, is regressed on all the other variables, included imputed values of smoking and restricting estimation to individuals with observed values for the variable to impute. Again, missing values for age at menarche are replaced by draws from the posterior predictive distribution. This process is repeated until a stable imputation is found for all values of all variables. Following this process we created five imputed data sets that were used for subsequent analyses. The final effect association is a weighted average of the effects found in these five datasets.

The association of the WCRF/AICR score with BC risk was evaluated using conditional logistic regression models with robust estimation of standard errors, both in categories and as a continuous term (considering the risk associated to one-unit decrease in the score). Same models where used to explore the association between the accomplishment of the individual recommendations and BC risk. All models included the following potential confounders: total calorie intake, smoking habit, age at first delivery, education, history of breast problems, family history of BC and menopausal status. Models for noncompliance of individual recommendations were also adjusted for the overall score obtained by adding up all the individual recommendations except the one under study. This approach was selected instead of adjusting for individual recommendations to avoid introducing collinearity in the models caused by the high dependence among them. Possible differences by menopausal status were assessed using interaction terms (1 df) between WRCF/AICR score/individual recommendations and menopausal status.

Multinomial logistic regression models were used to evaluate the association of the WCRF/AICR score/individual recommendations with each of the aforementioned intrinsic BC subtypes. These models were adjusted for age, hospital, and the same set of potential confounders described above.

The Wald test was used to compare the dose-response effect for each tumor subtype.

Assuming a causal relationship between the score WCRF/AICR and BC risk, the population attributable fraction (PAF%) was calculated using Levi's formula [25] to estimate the proportion of total cancer in this population that hypothetically would not have occurred if all participants were in the highest category of the score (6 or more recommendations met). Confidence intervals for PAF were computed using bootstrap with 1000 iterations.

Fractional polynomials were also used to explore the shape of the dose-response association between the score and BC risk [26].

Finally, a complete case analysis [23] was carried out for all models to check the validity of the imputation.

Analyses were performed in 2014 using STATA/MP 12.0 software.

Results

After excluding 44 case-control pairs (n = 88) because of implausible reported energy intakes (<750 or >4500 kcal/day) [27] information in either the case or the control, final analyses were based on 973 cases-control pairs aged 22 to 71.

Compared to controls, BC cases seemed to accomplish less WCRF/AICR recommendations have higher age at first delivery, a lower education level, a larger proportion of breast problems and of family history of BC and a higher calorie intake (Table 2).

thumbnail
Table 2. Distribution WCRF/AICR score and individual recommendations and other baseline characteristics for cases and controls.

https://doi.org/10.1371/journal.pone.0126096.t002

Table 3 summarizes the results for the association between the WCRF/AICR scores and individual recommendations and BC risk by menopausal status. Despite the fact that the BC risk appeared to increase linearly with the decrease in the WCRF/AICR score, the categorical analyses showed the most significant risk for women with a score below 4. Women that accomplish only 3 recommendations showed a two-fold increased risk of BC than women in the upper category (OR = 2.09 (CI95%:1.46;2.99)) and women meeting less than 3 recommendations showed a three-fold increase in such a risk (OR[0–3[vs[6–9] = 2.98 (CI95%:1.59–5.59)). The risk was higher in postmenopausal (OR[0–3[vs[6–9] = 3.60 (CI95%:(1.24;10.47)) than in premenopausal women (OR[0–3[vs[6–9] = 2.66 (CI95%:(1.23;5.76)), but confidence intervals overlap and the p-value for the interaction term in the continuous model was not statistically significant. The proportion of preventable cases of BC in this population by following 6 or more recommendations was estimated at around 30% for all women and also by menopausal status groups. Regarding specific items, diet related individual recommendations showed the strongest associations. In fact, noncompliance with recommendation 3 “Limit the intake of high density food” had an excess risk of 1.86 (CI95%:1.15;3.01), especially in premenopausal women (OR = 2.24 (CI95%: (1.18–4.28); p for interaction = 0.014), while a low intake of plant foods was also associated with BC (OR = 1.65 (CI95%:(1.08;2.57)), particularly among postmenopausal women (OR = 2.35 (CI95%:(1.24;4.44)), although the p-value for heterogeneity was not significant. The odds ratio of BC for women with alcohol consumption above the recommended was over 1.30 in all cases, however, none of these estimations showed statistical significance, probably given to the fact that most women (94% of controls and 95% of cases) meet totally or partially this specific recommendation.

thumbnail
Table 3. Association of WCRF/AICR score and individual recommendations with breast cancer risk by menopausal status.

https://doi.org/10.1371/journal.pone.0126096.t003

Regarding the analyses by pathological subtype, even though no statistically significant differences were observed between subtypes, the increased risk for the lack of compliance with the WCRF/AICR recommendations was especially high for women with ER+/PR+&HER2- (OR[0–3[vs[6–9] = 3.60 (CI95%:(1.84;7.05) and OR[3–4[vs[6–9] = 2.18 (CI95%:(1.50;3.16)) and HER+ tumors (OR[0–3[vs[6–9] = 4.23 (CI95%:(1.66;10.78)). Triple negative tumors were also associated with the WCRF/AICR score in the lower category (OR[0–4[vs[6–9] = 2.32 (CI95%:(1.20;4.46)). The highest preventable effect of the WCRF/AICR guidelines was observed for ER+/PR+&HER2- (PAF95%CI: 35% (17%;53%)) and HER+ (PAF95%CI:34% (5%;62%)) tumors while such effect was not significant for the triple negative subtype. Again, for individual items, diet-related recommendations seemed to be the most important, particularly the consumption of foods and drinks that promote weight gain above the recommended which showed OR ranging from 1.68 for ER+/PR+/HER2- tumors to 2.93 for triple negative tumors, though the p-value for heterogeneity was not statistically significant. Low consumption of plant foods seemed to be specifically associated with triple negative tumors (OR = 3.48 (CI95%:(1.46–8.31)), with a p-value of heterogeneity of 0.148 while consumption of alcoholic drinks was only significantly associated with ER+/PR+&HER2- tumors (OR = 1.52 (CI95%:(1.06–2.19)) (Table 4).

thumbnail
Table 4. Association of WCRF/AICR score and individual recommendations with breast cancer risk by intrinsic tumor subtype.

https://doi.org/10.1371/journal.pone.0126096.t004

The exploration of non-linear associations using fractional polynomials revealed that the linear model was the best fit when a continuous association was found (S1 Fig).

Sensitivity analyses gave similar results leading to the same conclusions (S1 and S2 Tables).

Discussion

Summary

Our results suggest that WCRF/AICR recommendations may help to prevent overall BC risk, especially among postmenopausal women and women with ER+/PR+&HER2- or HER+ tumor subtypes. Diet related individual recommendations seemed to be the factors more strongly associated with BC risk, especially a high consumption of high density foods or alcohol and the low intake of plant foods.

Comparison with other studies

To our knowledge only four studies have explored the association between BC risk and the WCRF/AICR recommendations: two in the US, one in Canada and another using the European EPIC cohort, showing similar results to ours [1215]. All of them report a significant linear negative trend for the association between the number of recommendations met and BC risk and two of them also identified women that meet 3 or less recommendations as the higher risk group [13,14]. Two of these studies also explored the specific relationship between individual recommendations and BC risk [12,15] and the authors found the strongest associations with the recommendations related to body fatness and food and alcohol intake that go in the same direction as ours.

Specific literature exploring the individual items that compose the WCRF/AICR score in relation with breast cancer, has pointed through a negative or non-significant effect of BMI or physical activity on the incidence of BC in premenopausal women and a positive association with postmenopausal breast cancer [10,11,2830]. Our results, though not statistically significant, point in the same direction. Concerning diet and breast cancer, strong evidence is only available for the negative effect of alcohol consumption [10,11,31]. However some studies in low and medium income countries with greater dietetic variability suggested other interesting associations [31]. In this sense, various studies support our finding of a protective effect of plant foods intake against BC [32,33], particularly against RE-PR- tumors [34,35]. This is in agreement with the stronger effect we observed for triple negative tumors. Regarding the influence of foods and drinks that promote weight gain on BC development, to our knowledge, no specific studies have explored this association. The purpose of the third recommendation is to prevent cancer risk through a better control of body weight reducing the intake of energy-dense foods [10,11,36]. However, it is possible that the detrimental effect of this type of foods goes beyond the excess risk associated with an increase in body-weight, as our results suggest. Energy-dense foods not only include high-fat dietary products, but also highly sugared and processed foods that might have an effect on BC risk. The consumption of this type of food increases the risk especially in premenopausal women with higher adherence to a western-style diet [27].

The evidence of an association between consumption of red meat and processed food and BC is still weak [33,37,38], but it is in agreement with our results regarding recommendations 5 and 7. Despite the fact that alcohol is the only nutritional factor for which strong evidence of a positive association exists [10,11,31], we only identified a positive significant association with alcohol for women with ER+/PR+&HER2- tumors, even though results point through a positive association for BC in general. Our women did not report a high consumption of alcohol (only 79 cases and 61 controls reported an ethanol intake ≥20g/d) therefore differences between women in this case might be insufficient to obtain significant associations with the current sample size. Contrary to what is known for other tumors, vitamin supplementation has not been negatively associated with BC. In fact, some studies about supplementation with nutrients like vitamin C, D and E or calcium, to prevent BC have been published but the evidence is still insufficient to reach conclusions [3942]. Finally, breast feeding appears to be a well-established protective factor for BC [10,11], but, we did not find a significant association in the analyses. In our sample only 28% of women did not breastfeed, being 97% of them nulliparous. These proportions might be too small to obtain significant results.

Regarding the potential preventability of the WCRF/AICR recommendations observed in our study, it is in concordance with the results published in the Policy and Action for Cancer Prevention Report [36] whose estimates for USA, UK, Brazil and China were 38%, 42%, 28% and 20% respectively.

Limitations and Strengths

Recall bias is always a concern in case-control studies; however, the validity and reproducibility of FFQ was satisfactory [21,22] and the strength of the associations deemed it unlikely that our findings are a result of this bias. Secondly, statistical power was limited in the subgroup analyses by intrinsic tumor subtype and therefore the results should be interpreted with caution. On the other hand, the matching design resulted in closely related cases and controls which would bias the OR towards the null effect. In spite of these limitations, we were able to detect a consistent dose-response gradient for the association between BC and WCRF/AICR score, even in the stratified and subgroup analyses.

Except for the cases of the specific subrecommendations related to moldy cereals or pulses, we were able to operationalize all general and specific WCRF/AICR recommendations applicable to this population. No previous studies have been able to operationalize all the recommendations with their data and only one was able to explore the individual association between BC risk and 6 out of the 9 recommendations. On the other hand, this is the first study that explores such associations by menopausal status and BC pathological subtype including ER, PR and HER2 status.

Finally, Spain is a country that has traditionally maintained healthy dietary habits. In fact, almost 60% of the control population met 5 or more recommendations and 90% of our women accomplish somehow the most important recommendations on food (R1 and R4) and alcohol consumption (R6) (S4 Table). However, our results suggest that our women can still benefit from a greater adherence to the WCRF/AICR recommendations.

Conclusions

BC prevention might be possible by following the WRCF/AICR recommendations, even in settings like Spain, where a high percentage of women already comply with many of them. Despite the fact that especial benefit can be obtained by avoiding the consumption of foods and drinks that promote weight gain, limiting alcohol intake and increasing the consumption of plant foods, our results indicate that a good level of satisfaction with most of the recommendations is more important than any single recommendation.

Supporting Information

S1 Fig. Graphical representation of best polynomial fit for all women and stratifying by menopausal status and type of tumor including p-value for departure from linearity.

https://doi.org/10.1371/journal.pone.0126096.s001

(PDF)

S1 Table. Association of WCRF/AICR score with breast cancer risk by menopausal status.

Complete case analysis.

https://doi.org/10.1371/journal.pone.0126096.s002

(DOCX)

S2 Table. Association of WCRF/AICR score with breast cancer risk by intrinsic tumor subtype.

Complete case analysis.

https://doi.org/10.1371/journal.pone.0126096.s003

(DOCX)

S3 Table. Number and percentage of recommendations accomplished by cases and controls.

https://doi.org/10.1371/journal.pone.0126096.s004

(DOCX)

S4 Table. Names of all approving ethics committees.

https://doi.org/10.1371/journal.pone.0126096.s005

(DOCX)

Acknowledgments

The authors wish to thank the participants in the Epi-GEICAM study for their contribution to breast cancer research. Other members of the Epi-GEICAM research group are listed here: Angels Arcusa Lanza, Ferrán Moreno Sala, Encarna Adrover, Amparo Oltra, Joan Brunet, Sonia González, Raquel Andrés Conejero, Antonio Llombart, Blanca Hernando and Rosa Mª Franquesa.

Author Contributions

Conceived and designed the experiments: M. Martín AR AMC JMBC SA PS MR AA M. Muñoz ALL BB AJF CJ JIC MAJ PR ED VG EC BPG JV MP. Performed the experiments: M. Martín AR AMC JMBC SA PS MR AA M. Muñoz ALL BB AJF CJ JIC MAJ PR ED VG EC BPG JV MP. Analyzed the data: AC VL JV MP. Wrote the paper: AC MP.

References

  1. 1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277–300. pmid:20610543
  2. 2. WHO (2009) Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, World Health Organization, 2009.
  3. 3. Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J, et al. (2009) Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst 101: 1584–1591. pmid:19861303
  4. 4. WHO (2009) Women and health: today's evidence tomorrow's agenda. World Health Organisation. 9,40,52,63. p.
  5. 5. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765–781. pmid:20116997
  6. 6. EUCAN Estimated incidence, mortality & prevalence, 2012.
  7. 7. Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14: 1165–1174. pmid:24131614
  8. 8. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25: 2097–2116. pmid:18626751
  9. 9. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 15: R92. pmid:24286369
  10. 10. WCRF/AICR (2007) World Cancer Research Fund / American Institute for Cancer research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007. 289–295 p.
  11. 11. WCRF/AICR (2010) World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer.
  12. 12. Hastert TA, Beresford SA, Patterson RE, Kristal AR, White E (2013) Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 22: 1498–1508. pmid:23780838
  13. 13. Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, et al. (2012) Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 96: 150–163. pmid:22592101
  14. 14. Thomson CA, McCullough ML, Wertheim BC, Chlebowski RT, Martinez ME, Stefanick ML, et al. (2014) Nutrition and Physical Activity Cancer Prevention Guidelines, Cancer Risk, and Mortality in the Women's Health Initiative. Cancer Prev Res (Phila) 7: 42–53. pmid:24403289
  15. 15. Catsburg C, Miller AB, Rohan TE (2014) Adherence to cancer prevention guidelines and risk of breast cancer. Int J Cancer.
  16. 16. Castello A, Pollan M, Buijsse B, Ruiz A, Casas AM, Baena-Cañada JM, et al. (2014) Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. Br J Cancer.
  17. 17. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. (2011) Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22: 1736–1747. pmid:21709140
  18. 18. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. (2010) American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28: 2784–2795. pmid:20404251
  19. 19. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31: 3997–4013. pmid:24101045
  20. 20. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51–65. pmid:4014201
  21. 21. Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A (2007) Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr 97: 977–986. pmid:17408529
  22. 22. Vioque J, Navarrete-Munoz EM, Gimenez-Monzo D, Garcia-de-la-Hera M, Granado F, Young IS, et al. (2013) Reproducibility and validity of a food frequency questionnaire among pregnant women in a Mediterranean area. Nutr J 12: 26. pmid:23421854
  23. 23. White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 30: 377–399. pmid:21225900
  24. 24. Royston P, White IR (2011) Multiple Imputation By Chained Equiations (MICE): Implementation in Stata. Journal of Statistical Software 45: 1–19. pmid:22289957
  25. 25. Hanley JA (2001) A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 55: 508–514. pmid:11413183
  26. 26. Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28: 964–974. pmid:10597998
  27. 27. Garcia-Arenzana N, Navarrete-Munoz EM, Peris M, Salas D, Ascunce N, Gonzalez I, et al. (2012) Diet quality and related factors among Spanish female participants in breast cancer screening programs. Menopause 19: 1121–1129. pmid:22760085
  28. 28. Inumaru LE, Silveira EA, Naves MM (2011) [Risk and protective factors for breast cancer: a systematic review]. Cad Saude Publica 27: 1259–1270. pmid:21808811
  29. 29. Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186: 13–42. pmid:21113759
  30. 30. Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti Irani A (2012) Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One 7: e51446. pmid:23236502
  31. 31. Romieu I (2011) Diet and breast cancer. Salud Publica Mex 53: 430–439. pmid:22218797
  32. 32. Aune D, Chan DS, Vieira AR, Rosenblatt DA, Vieira R, et al. (2012) Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 134: 479–493. pmid:22706630
  33. 33. Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV (2010) Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 91: 1294–1302. pmid:20219961
  34. 34. Baglietto L, Krishnan K, Severi G, Hodge A, Brinkman M, English DR, et al. (2011) Dietary patterns and risk of breast cancer. Br J Cancer 104: 524–531. pmid:21157446
  35. 35. Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, Adams-Campbell LL, et al. (2010) Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study. Am J Epidemiol 172: 1268–1279. pmid:20937636
  36. 36. WCRF/AICR (2009) World Cancer Research Fund / American Institute for Cancer Research. Policy and Action for Cancer Prevention. Food, Nutrition, and Physical Activity: a Global Perspective. Washington DC: AICR.
  37. 37. Alexander DD, Morimoto LM, Mink PJ, Cushing CA (2010) A review and meta-analysis of red and processed meat consumption and breast cancer. Nutr Res Rev 23: 349–365. pmid:21110906
  38. 38. Taylor VH, Misra M, Mukherjee SD (2009) Is red meat intake a risk factor for breast cancer among premenopausal women? Breast Cancer Res Treat 117: 1–8. pmid:19543971
  39. 39. Bristow SM, Bolland MJ, MacLennan GS, Avenell A, Grey A, Gamble GD, et al. (2013) Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br J Nutr 110: 1384–1393. pmid:23601861
  40. 40. Chlebowski RT (2011) Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res 13: 217. pmid:21884640
  41. 41. Harris HR, Bergkvist L, Wolk A (2013) Vitamin C intake and breast cancer mortality in a cohort of Swedish women. Br J Cancer 109: 257–264. pmid:23736027
  42. 42. Stoll F, Akladios CY, Mathelin C (2013) [Vitamin D and breast cancer: is there a link?]. Gynecol Obstet Fertil 41: 242–250. pmid:23562418